Targeted Medical Pharma, Inc.
TRGM
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Net Income | 60.80% | 76.54% | -29.06% | -72.23% | -398.31% |
| Total Depreciation and Amortization | -45.30% | -47.89% | -42.23% | -35.52% | -4.77% |
| Total Amortization of Deferred Charges | 12.97% | -28.61% | -19.01% | -33.36% | 0.00% |
| Total Other Non-Cash Items | -26.33% | -112.26% | -632.26% | -87.24% | 686.11% |
| Change in Net Operating Assets | -71.50% | -65.26% | -33.43% | -90.47% | 153.45% |
| Cash from Operations | -67.82% | -29.87% | -106.02% | -1,820.37% | 112.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 344.44% | -344.44% | -- |
| Cash from Investing | -- | -- | 344.44% | -344.44% | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -100.00% |
| Total Debt Repaid | 57.04% | 56.12% | 63.91% | 69.22% | 48.22% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 94.56% | 23.17% | 63.91% | 620.29% | -112.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 315.28% | -105.19% | -199.41% | 152.96% | -108.89% |
